Methylphenidate vs. Risperidone for the Treatment of Children and Adolescents With ADHD and Disruptive Disorders

Clinical Trial ID NCT02063945

Rank	Title	Journal	Year	PubWeight™‹?›
1	ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents.	Pediatrics	2011	5.46
2	The Children's Sleep Habits Questionnaire (CSHQ): psychometric properties of a survey instrument for school-aged children.	Sleep	2000	5.27
3	A depression rating scale for children.	Pediatrics	1979	1.99
4	Antipsychotics for children and young adults: a comparative effectiveness review.	Pediatrics	2012	1.93
5	Factor structure of the Young Mania Rating Scale for use with youths ages 5 to 17 years.	J Clin Child Adolesc Psychol	2002	1.26
6	A review of attention-deficit/hyperactivity disorder complicated by symptoms of oppositional defiant disorder or conduct disorder.	J Dev Behav Pediatr	2010	1.07
7	Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options.	Eur Child Adolesc Psychiatry	2012	0.97
8	Risperidone augmentation for treatment-resistant aggression in attention-deficit/hyperactivity disorder: a placebo-controlled pilot study.	J Am Acad Child Adolesc Psychiatry	2007	0.97